#early cancer detection

Discover 2 curated intelligence briefings related to this specific topic.

The End of the Waiting Game: How MCEDs are Redefining Cancer Detection
Health & Medicine

The End of the Waiting Game: How MCEDs are Redefining Cancer Detection

The oncology landscape is undergoing a seismic shift as multi-cancer early detection (MCED) tests move from experimental research to regulatory milestones. With the market projected to hit $21.4 billion by 2034, the 'wait and see' era of diagnosis is being replaced by high-sensitivity liquid biopsies.

Read Analysis
The Blood-Print Revolution: Why the Era of the Surgical Biopsy is Ending
Health & Medicine

The Blood-Print Revolution: Why the Era of the Surgical Biopsy is Ending

The medical world is witnessing a quiet but violent displacement of traditional oncology. Liquid biopsies, once a futuristic promise, are now fundamentally altering how we detect and monitor malignancy across the globe.

Read Analysis